血管紧张素II激活NF-κB通路加重非搏动性灌注肾损伤
该研究在大鼠ECLS模型中比较搏动性与非搏动性灌注对肾损伤的影响,每组n=6,灌注4小时后采血及肾组织。非搏动组肾损伤标志物更高、NF-κB信号富集、Ang II升高;卡托普利干预后Ang II及炎症反应下降。
要点
- 非搏动性灌注与更高的BUN、Scr、KIM-1、Cys-C水平相关
- 非搏动组NF-κB信号显著富集且Ang II表达升高并与炎症相关
- 卡托普利(50 mg/kg腹腔注射)干预显示减轻炎症的趋势,属探索性结果
核心结论
- 大鼠ECLS模型中搏动性灌注较非搏动性灌注的肾损伤及炎症标志物水平更低,可能涉及Ang II表达的调节。
- 非搏动条件下给予卡托普利可能降低NF-κB激活与炎症反应,但结果属探索性,需在临床相关模型中进一步验证。
研究设计与样本
- 沿用既往建立的大鼠ECLS模型,Sprague-Dawley大鼠每组n=6。
- 以VA-ECMO和VV-ECMO模式分别模拟非搏动性与搏动性灌注,灌注4小时后采集血清和肾组织。
- 非搏动组设治疗亚组,灌注前15分钟腹腔注射卡托普利50 mg/kg。
- 采用转录组分析、Western blotting与实时定量PCR探索分子机制。
主要发现
- 与搏动性灌注组相比,非搏动组的BUN、Scr、KIM-1、Cys-C水平更高。
- 转录组分析显示非搏动组NF-κB信号显著富集。
- 非搏动组Ang II表达显著升高,并与炎症相关。
- 非搏动组中接受卡托普利的大鼠Ang II表达降低,肾损伤标志物呈下降趋势,炎症反应受抑,NF-κB激活减少。
临床怎么用
- 提示ECLS中灌注模式可能影响肾功能,非搏动性灌注时需关注肾损伤标志物。
- 卡托普利相关观察仅为动物实验探索性结果,不能直接外推为临床用药推荐。
局限性
- 研究为大鼠ECLS模型,样本量小(每组n=6),结果属探索性。
- 结论需在临床相关模型中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Non-pulsatile perfusion is a widely used mode of blood flow in extracorporeal life support (ECLS). In contrast to physiological pulsatile perfusion, non-pulsatile perfusion has been linked to renal injury. This study aims to investigate the differential effects of pulsatile and non-pulsatile perfusion on renal injury. METHODS: We utilized a previously established ECLS model in Sprague-Dawley rats (n = 6 per group). Non-pulsatile and pulsatile perfusion were modelled using veno-arterial (VA) and veno-venous (VV) extracorporeal membrane oxygenation (ECMO) modes, respectively, to emulate the haemodynamic features of different flow patterns. Following 4 hours of perfusion, serum and renal tissue samples were collected for analysis. Renal injury biomarkers, including blood urea nitrogen (BUN), serum creatinine (Scr), kidney injury molecule 1 (KIM-1), and cystatin C (Cys-C), were quantified. Transcriptomic analysis, Western blotting, and quantitative real-time polymerase chain reaction (PCR) were employed to explore molecular mechanisms. In the non-pulsatile group, a treatment subgroup was administered captopril (50 mg/kg, intraperitoneally, 15 min before perfusion) to evaluate the role of Ang II in renal injury. RESULTS: Compared with the non-pulsatile group, the pulsatile perfusion group showed lower levels of biomarkers associated with renal injury, as reflected by reduced levels of BUN, Scr, KIM-1, and Cys-C. Transcriptomic analysis revealed significant enrichment of NF-κB signalling in the non-pulsatile group. Angiotensin II (Ang II) expression was significantly higher in the non-pulsatile group and correlated with inflammation. In the non-pulsatile perfusion group, rats receiving captopril exhibited reduced Ang II expression and showed trends towards lower renal injury biomarkers, suppressed inflammatory responses, and decreased NF-κB activation. CONCLUSIONS: These findings in a rat ECLS model suggest that pulsatile perfusion is associated with lower levels of renal injury-related and inflammatory markers compared to non-pulsatile perfusion, potentially involving modulation of Ang II expression. Preliminary observations also indicate that captopril administration under non-pulsatile conditions may be linked to reduced NF-κB activation and inflammatory responses. However, these results are exploratory in nature and require further validation in clinically relevant models.
引用
- Shen X, Zhang X, Li J, et al. Activation of the NF-κB Signalling Pathway by Angiotensin II Aggravates Renal Inflammatory Injury During Non-Pulsatile Perfusion. Eur J Cardiothorac Surg. 2025. PMID: 41042896. doi:10.1093/ejcts/ezaf337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。